Dystrophin modifications by CRISPR/Cas9 have been proven to be a fast way to rescue DMD, with efficient restoration of CM contractility and calcium transients detected to varying degrees [61]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.